JamesMichaelClarkMD

PubMed

• Variability in Smoking Status for Lobectomy Among Society of Thoracic Surgeons Database Participants.
  Clark JM, Kozower BD, Kosinski AS, Chang A, Broderick SR, David EA, Block M, Schipper PH, Welsh RJ, Seder CW, Farjah F, Brown LM> ;The Annals of thoracic surgery. 2020-10-01
• Engagement and Effectiveness of a Smoking Cessation Quitline Intervention in a Thoracic Surgery Clinic.
  Mustoe MM, Clark JM, Huynh TT, Tong EK, Wolf TP, Brown LM, Cooke DT> ;JAMA surgery.
• Cardiopulmonary Testing Before Lung Resection: What Are Thoracic Surgeons Doing?
  Clark JM, Marrufo AS, Kozower BD, Tancredi DJ, Nuño M, Cooke DT, Pollock BH, Romano PS, Brown LM> ;The Annals of thoracic surgery. 2019-06-07
• Does one size fit all? An evaluation of the 2018 Leapfrog Group minimal hospital and surgeon volume thresholds for lung surgery.
  Clark JM, Cooke DT, Chin DL, Utter GH, Brown LM, Nuño M> ;The Journal of thoracic and cardiovascular surgery. 2019-10-01
• 16 citations
  Can the Risk Analysis Index for Frailty Predict Morbidity and Mortality in Patients Undergoing High-Risk Surgery?
  James M. Clark, Miriam A Nuno, David T. Cooke, Lisa M. Brown> ;Annals of Surgery. 2020 Nov 17
• ICD-10-CM/PCS: potential methodologic strengths and challenges for thoracic surgery researchers and reviewers.
  Clark JM, Utter GH, Nuño M, Romano PS, Brown LM, Cooke DT> ;Journal of thoracic disease.
• Regionalization of esophagectomy: where are we now?
  Clark JM, Boffa DJ, Meguid RA, Brown LM, Cooke DT> ;Journal of thoracic disease.
• Do the 2018 Leapfrog Group Minimal Hospital and Surgeon Volume Thresholds for Esophagectomy Favor Specific Patient Demographics?
  Clark JM, Cooke DT, Hashimi H, Chin D, Utter GH, Brown LM, Nuño M> ;Annals of surgery.
• TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4 NON-SMALL CELL LUNG CANCER.
  Clark JM, Heifetz LJ, Palmer D, Brown LM, Cooke DT, David EA> ;Cancer treatment and research communications.
• 46 citations
  COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The Annals of Thoracic Surgery. 2020 Aug 1
• 88 citations
  COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The Journal of Thoracic and Cardiovascular Surgery. 2020 Aug 1
• Survival benefits associated with surgery for advanced non-small cell lung cancer.
  David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ> ;The Journal of thoracic and cardiovascular surgery. 2018-11-14
• The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.
  David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017-08-24
• 25 citations
  Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
  Robert Medairos, James M. Clark, Simon Holoubek, John C. Kubasiak, Ravi Pithadia, Fatima Hamid, Gary W. Chmielewski, William H. Warren, Sanjib Basu, Jeffrey A. Borgia,...> ;The Journal of Thoracic and Cardiovascular Surgery. 2016 Jul 1
• 4 citations
  Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial
  Edward P. Sloan, Max Koenigsberg, W. Brad Weir, James M. Clark, Robert E. O'Connor, Michael Olinger, Rita K. Cydulka> ;Prehospital and Disaster Medicine. 2015 Feb 1
• 31 citations
  Shock index and prediction of traumatic hemorrhagic shock 28-day mortality: data from the DCLHb resuscitation clinical trials.
  Edward P. Sloan, Max Koenigsberg, James M. Clark, William Bradley Weir, Nora Philbin> ;The Western Journal of Emergency Medicine. 2014 Jan 1
• 3 citations
  The use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials.
  Edward P. Sloan, Max Koenigsberg, James M. Clark, Amol Desai> ;Prehospital and Disaster Medicine. 2012 Aug 1
• Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal cell carcinoma.
  Clark, J. M.,Kelley, B.,Titze, J.,Fung, H.,Maciejewski, J.,Nathan, S.,Rich, E.,Basu, S.,Kaufman, H. L.> ;Oncology. 2012 Dec 14
• Join now to see all